A detailed history of Cwm, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Cwm, LLC holds 34,167 shares of XERS stock, worth $115,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,167
Previous 17,637 93.72%
Holding current value
$115,142
Previous $40,000 142.5%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$2.06 - $2.96 $34,051 - $48,928
16,530 Added 93.72%
34,167 $97,000
Q2 2024

Jul 09, 2024

BUY
$1.7 - $2.45 $7,571 - $10,912
4,454 Added 33.79%
17,637 $40,000
Q1 2024

Apr 05, 2024

BUY
$2.04 - $3.22 $26,854 - $42,388
13,164 Added 69284.21%
13,183 $29,000
Q4 2023

Feb 01, 2024

BUY
$1.47 - $2.36 $27 - $44
19 New
19 $0

Others Institutions Holding XERS

About Xeris Biopharma Holdings, Inc.


  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $458M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.